Back

Impact of integrated care in patients with heart failure with reduced ejection fraction: a report from the WARCEF trial

27 August 2023 (09:40 - 09:50)
Organised by: Logo
Congress Presentation Part of: Insights from recent HFrEF trials 2 Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Associate Professor Marco Proietti

University of Milan, Milan (Italy)

5 More presentations in this session

Presentation thumbnail
Diuretic use and outcomes in patients with HFrEF: Insights from the VICTORIA trial
Doctor J. Ezekowitz (Edmonton, CA)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis
Doctor D. Vukadinovic (Homburg, DE)
Abstract Slides Video
Presentation thumbnail
Scar characterisation to predict arrhythmia and death in ischaemic cardiomyopathy: insights from the REVIVED trial
Doctor H. Morgan (London, GB)
Abstract Slides Video
Presentation thumbnail
Effect of eplerenone according to duration of heart failure in EMPHASIS-HF: It is never too late to start an MRA in HFrEF
Doctor S. Matsumoto (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
A national heart failure initiative is associated with improved use of quadruple guideline-directed medical therapy
Doctor A. Sauer (Kansas City, US)
Abstract Slides Video

Access the full session

Session thumbnail
Insights from recent HFrEF trials 2
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 09:40 CET
You may be interested in
thumbnail
Congress Session
Insights from recent HFrEF trials 2
thumbnail
Congress Session
Smaller trials, trial updates, and other studies on heart failure (2)
thumbnail
Congress Session
Treatment of HFrEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources